In 2010 the FDA’s Drug Safety and Risk Management Advisory Committee held 13 days of meetings encompassing discussion of 10 drugs and two drug classes. In 2009 the committee held six days of meetings regarding four drugs and one class.
Discuss.
“Meetings are indispensable when you don’t want to do anything.”
-- John Kenneth Galbraith